| 2003 | | Sensitization rates for inhalant allergens in Korea: a multi-center study | 박해심 |
| 2005 | | Sensitization Rates for Inhalant Allergens in Patients with Respiratory Allergy in Busan | 남동호, 박해심 |
| 2022 | | Serum Amyloid A1: A Biomarker for Neutrophilic Airway Inflammation in Adult Asthmatic Patients | 박해심, 신유섭, 최영우 |
| 2016 | | Serum Clusterin as a Prognostic Marker of Chronic Spontaneous Urticaria | 박해심, 반가영, 신유섭, 예영민 |
| 2003 | | Serum cytokine profiles in patients with adult onset Still's disease. | 남동호, 박해심, 서유진, 서창희, 최정희 |
| 2011 | | Serum cytokines markers in toluene diisocyanate-induced asthma. | 박해심, 예영민 |
| 2021 | | Serum Human β-Defensin 2 Is Increased in Angioedema Accompanying Chronic Spontaneous Urticaria | 박해심, 예영민 |
| 2003 | | Serum IgG and IgG subclass in aspirin-sensitive asthma | 남동호, 박해심 |
| 1999 | | Serum IgG and IgG subclass in bronchial asthma | 김선신, 남동호, 박해심, 이재옥 |
| 2019 | | Serum Levels of Eosinophil-Derived Neurotoxin: A Biomarker for Asthma Severity in Adult Asthmatics | 박해심, 이영수 |
| 2013 | | Serum metabolomics reveals pathways and biomarkers associated with asthma pathogenesis. | 김승현, 박해심 |
| 2024 | | Serum MRGPRX2 as a Long-term Biomarker for Iodinated Contrast Media-Induced Anaphylaxis | 예영민 |
| 2018 | | Serum Periostin Levels: A Potential Serologic Marker for Toluene Diisocyanate-Induced Occupational Asthma | 박해심, 신유섭, 예영민 |
| 2020 | | Serum potential biomarkers according to sputum inflammatory cell profiles in adult asthmatics | 박해심, 예영민 |
| 2015 | | Serum S100A8 and S100A9 Enhance Innate Immune Responses in the Pathogenesis of Baker's Asthma. | 김승현, 박해심, 반가영, 신유섭, 예영민 |
| 2004 | | Serum Specific IgE to Staphylococcal Superantigens in Sera of ASA-intolerant Asthma | 남동호, 박해심, 서창희 |
| 2015 | | Serum Specific IgE to Thyroid Peroxidase Activates Basophils in Aspirin Intolerant Urticaria. | 박해심, 신유섭, 예영민 |
| 2014 | | Serum specific IgG response to toluene diisocyanate-tissue transglutaminase conjugate in toluene diisocyanate-induced occupational asthmatics. | 박해심, 신유섭 |
| 2021 | | Serum-free immunoglobulin E: A useful biomarker of atopy and type 2 asthma in adults with asthma | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2018 | | Severe asthma and high doses of corticosteroid adversely impact trabecular bone score more than bone mineral density | 박해심, 예영민, 윤덕용, 최용준 |
| 2021 | | Severe cutaneous adverse reactions to anti-tuberculosis drugs in korean patients | 예영민 |
| 2019 | | Severe Cutaneous Adverse Reactions to Antiepileptic Drugs: A Nationwide Registry-Based Study in Korea | 예영민 |
| 2016 | | Shifting p53-induced senescence to cell death by TIS21(/BTG2/Pc3) gene through posttranslational modification of p53 protein | 유민숙, 임인경 |
| 2002 | | Skin reactivity and specific IgE sensitization to Tetranychus urticae and identification of IgE binding components | 김현아, 박해심, 최정희 |
| 2023 | | Skin Test–Guided Strategy to Select Alternative Iodinated Contrast Media in Patients With Immediate Hypersensitivity Reaction: A Prospective Confirmative Study | 예영민 |
| 2021 | | Specialist perception of severe asthma in Korea: A questionnaire survey | 이영수 |
| 2021 | | Specific antibody deficiency in adult patients with igg or igg subclass deficiency | 박해심, 장재혁 |
| 2003 | | Specific IgE determination to shrimp (Metapenaeus joyneri) and identification of its allergen | 남동호, 박해심, 서유진, 서창희, 최정희 |
| 1999 | | Specific IgG, but not specific IgE, antibodies to toluene diisocyanate-human serum albumin conjugate are associated with toluene diisocyanate bronchoprovocation test results. | 남동호, 박해심 |
| 2002 | | Specific immunoglobulin E and immunoglobulin G antibodies to toluene diisocyanate-human serum albumin conjugate: useful markers for predicting long-term prognosis in toluene diisocyanate-induced asthma. | 남동호, 박해심 |
| 2004 | | Specific immunoglobulin E for staphylococcal enterotoxins in nasal polyps from patients with aspirin-intolerant asthma. | 김승현, 김현준, 남동호, 박해심, 서창희 |
| 2021 | | Sputum antinuclear antibody serves as a biomarker for severe asthma | 박해심, 신유섭 |
| 1998 | | Sputum induction method for studying total IgE levels in atopic asthmatic patients | 남동호, 박해심, 서창희 |
| 2024 | | ST2-Mediated Neutrophilic Airway Inflammation: A Therapeutic Target for Patients With Uncontrolled Asthma | 박해심, 신유섭, 장재혁, 최영우 |
| 2007 | | Stem cell-based cell therapy for spinal cord injury. | 김병곤, 이승임 |
| 2016 | | Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Associated with Acetaminophen Use during Viral Infections | 박해심, 반가영, 예영민, 유혜수 |
| 2017 | | Subcutaneous Immunotherapy for Allergic Asthma in a Single Center of Korea: Efficacy, Safety, and Clinical Response Predictors | 남동호, 박해심, 반가영, 신유섭, 예영민, 이지호, 정창규 |
| 2012 | | Successful treatment of chronic eosinophilic pneumonia with anti-IgE therapy | 박해심, 신유섭, 예영민, 유혜수 |
| 2007 | | Successful treatment of pediatric systemic polyarteritis nodosa with cholestatic hepatitis. | 박해심, 서창희, 예영민 |
| 2019 | | Surfactant protein D alleviates eosinophil-mediated airway inflammation and remodeling in patients with aspirin-exacerbated respiratory disease | 김승현, 박해심, 신유섭 |
| 2013 | | T-cell lymphoma presenting as drug rash with eosinophilia and systemic symptoms syndrome | 김미애, 남동호, 박해심, 신유섭, 유혜수 |
| 2005 | | TDI-induced Asthma and Immune Responses in TDI-exposed Workers | 박해심 |
| 2013 | | The allergenic potency of Japanese hop pollen is increasing with environmental changes in Korea. | 박해심, 신유섭, 예영민 |
| 2021 | | The blocking effect of the glycoprotein IIb/IIIa receptor in the mouse model of asthma | 박해심, 신유섭 |
| 2022 | | The burden of symptomatic patients with chronic spontaneous urticaria: a real-world study in Korea | 박해심, 예영민 |
| 2000 | | The clinical significance of thyroid auto-antibodies in patients with chronic idiopathic urticaria | 김선신, 남동호, 박해심, 서유진 |
| 2023 | | The effect of apigenin, an aryl hydrocarbon receptor antagonist, in Phthalate-Exacerbated eosinophilic asthma model | 박해심, 신유섭 |
| 2024 | | The effect of Bruton's tyrosine kinase (BTK) inhibitor in the eosinophilic asthma model of mouse | 박해심, 신유섭 |
| 2007 | | The Efficacy of Added Montelukast in Persistent Asthmatics Who Were Not Completely Controlled on Inhaled Corticosteroids and Inhaled Long-acting β2- agonists | 박해심 |
| 2018 | | The Fas Signaling Pathway Is a Common Genetic Risk Factor for Severe Cutaneous Drug Adverse Reactions Across Diverse Drugs | 박해심 |
